01-09-2007 | Clinical Article
Effects of the selective endothelin A (ETA) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage – preliminary results from a randomized clinical series
Published in: Acta Neurochirurgica | Issue 9/2007
Login to get access